- Release Date: 21/05/25 09:48
- Summary: Phase I Clinical Trial Dosing Update No 3
- Price Sensitive: Yes
- Download Document 245.1KB
- Forums
- ASX - By Stock
- Ann: Phase I Clinical Trial Dosing Update No 3
NYR
nyrada inc.
Add to My Watchlist
1.67%
!
29.5¢

Ann: Phase I Clinical Trial Dosing Update No 3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $62.37M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 29.5¢ | $46.42K | 156.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 82000 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 259493 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 82000 | 0.295 |
6 | 205000 | 0.290 |
6 | 131000 | 0.285 |
7 | 128285 | 0.280 |
2 | 10579 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 259493 | 4 |
0.310 | 29700 | 1 |
0.320 | 5000 | 1 |
0.325 | 75000 | 1 |
0.330 | 7200 | 1 |
Last trade - 14.27pm 11/08/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online